A beacon of
hope in healthcare
Explore ManufacturingWho we are
Apothecon is a research-led pharma company delivering niche APIs, peptides, and complex formulations under stringent global standards—making specialized, high-quality medicines accessible worldwide.
Global reach
With regulatory approvals and trusted partners in 100+ countries, our medicines reach patients across continents, improving lives every day.
Product Portfolio
Delivering niche APIs, peptides, and complex formulations that meet global healthcare needs with precision and care.
Capabilities that power progress
From molecule to market, our integrated capabilities span product development, global-grade manufacturing, and strategic partnerships — built to deliver precision, compliance, and scalability.
Niche API & Peptide Expertise
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Advanced Formulation Development
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
Global-Grade Manufacturing
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Contract Manufacturing (CDMO Services)
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
Niche API & Peptide Expertise
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Advanced Formulation Development
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
Global-Grade Manufacturing
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Contract Manufacturing (CDMO Services)
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
Niche API & Peptide Expertise
We specialize in complex molecules — including peptides, iron complexes, and chiral APIs — developed through innovative, non-infringing routes.
Advanced Formulation Development
Our R&D teams design 505(b)(2) formulations, oral solids, injectables, and nasal sprays tailored for therapeutic precision and patient ease.
Global-Grade Manufacturing
With USFDA, UK MHRA, WHO-GMP approved sites and SAP-powered controls, we deliver high-quality output at global regulatory standards.
Contract Manufacturing (CDMO Services)
Partner with us to scale your molecule — from technology transfer to commercial production — across APIs, oral solids, and complex formulations.
Commitment Beyond Medicines
Our CSR initiatives focus on education, healthcare, and sustainability — investing in students, society, and the planet.
Our Impact
Latest at apothecon
Discover our milestones, innovations, and global impact stories.
CPHI Worldwide 2025 Participation, Germany
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
New Manufacturing Facility Launch
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
Apothecon Pharma got recognized at FICCI Awards.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
CPHI Worldwide 2025 Participation, Germany
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
New Manufacturing Facility Launch
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
Apothecon Pharma got recognized at FICCI Awards.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
CPHI Worldwide 2025 Participation, Germany
Visit Apothecon at CPHI 2025, Germany at worldwide 2025 at Hall 12.0 , Booth No. D86. Date - October 28-30,2025
New Manufacturing Facility Launch
Apothecon Pharma is launching a new mfg. facility at Sayakha, Gujarat, India with peptide facility and FDF facility with a capacity of 1 Billion Tablets / Capsules.
Apothecon Pharma got recognized at FICCI Awards.
We got awarded for our groundbreaking innovation and contributions in developing distribution pathways for newly approved drugs targeting select Rare Diseases.
